Home › DiaSorin Receives CE Mark for Simplexa Group B Strep Assay

DiaSorin Receives CE Mark for Simplexa Group B Strep Assay

Oct 18, 2018

This article has been updated from a previous version to correct the technology used in the Meridian H. Pylori assay.

NEW YORK (GenomeWeb) – DiaSorin Molecular said today that it has received CE marking for its Simplexa Group B Strep Direct assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

What's Popular?

In Molecular Diagnostics

  1. Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

  2. Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

    Premium

  3. Predigen Diagnostics Developing Gene Expression Platform to Differentiate Bacterial from Viral Infections

    Premium

  4. BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost

  5. BioFluidica Applying Liquid Biopsy to Detect Leukemia While Reducing Biopsies

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.